LeMaitre Vascular, Inc. (LMAT) Dividend History

LeMaitre Vascular, Inc. is a medical device company specializing in the development, manufacture, and commercialization of surgical solutions for peripheral vascular and cardiac use. Established to address the needs of vascular surgeons, the company offers a broad portfolio of products including vascular grafts, angioplasty balloons, stents, and other devices used in minimally invasive surgical procedures. LeMaitre Vascular serves a global customer base with an emphasis on improving patient outcomes through innovative technology.

63 Second Avenue, Burlington, MA, 01803
Phone: 781-221-2266
Website: https://www.lemaitre.com
Dividend Yield: 0.89%
Dividend Frequency: Quarterly

Dividend History

Pay Date Amount Ex Dividend Date Record Date
May 29, 2025 $0.20 05/15/2025 05/15/2025
March 27, 2025 $0.20 03/13/2025 03/13/2025
December 05, 2024 $0.16 11/21/2024 11/21/2024
August 29, 2024 $0.16 08/15/2024 08/15/2024
May 30, 2024 $0.16 05/15/2024 05/16/2024
Show more

Dividends Summary

  • LeMaitre Vascular, Inc. has issued 58 dividend payments over the past 14 years
  • The most recent dividend was paid 54 days ago, on May 29, 2025
  • The first recorded dividend was paid on April 5, 2011
  • The highest dividend payout was $0.20 per share
  • The average dividend over this 14 year span is $0.08 per share
  • LeMaitre Vascular, Inc. has increased its dividend payments by 900.00% since 2011

Company News

  • Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

    Anteris Technologies Global Corp. announced the appointments of David Roberts and Gregory Moss to its Board of Directors, as the company transitions to its next phase of growth with the upcoming global pivotal PARADIGM study for its DurAVR® Transcatheter Heart Valve.

    GlobeNewswire Inc.
    Featured Companies: AVR
  • Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?

    Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.

    Zacks Investment Research
    Featured Companies: DVA ECL MMSI
  • My Dividend Growth Portfolio

    I split my holdings into two categories: a core portfolio generating dividend payments and a growth portfolio generating both dividend and stock value growth.

    Seeking Alpha
    Featured Companies: AAPL ADP AVGO BEPC BLK BN FTS HD MGA MSFT QCOM RY SBUX SHOP TXN V
  • Navigating 4 Analyst Ratings For LeMaitre Vascular

    LeMaitre Vascular (NASDAQ:LMAT) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 2 0 0 0 2M Ago 1 0 0 0 0 3M Ago 0 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $82.75, along with a high estimate of $100.00 and a low estimate of $75.00. This current average reflects an increase of 24.12% from the previous average price target of $66.67. Understanding Analyst Ratings: A Comprehensive Breakdown A comprehensive examination of how financial experts perceive LeMaitre Vascular is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jason Wittes Roth MKM Announces Buy $100.00 - Michael Petusky Barrington Research Raises Outperform $79.00 $69.00 Daniel Stauder JMP Securities Raises Market Outperform $77.00 $72.00 Rick Wise Stifel Raises Buy $75.00 $59.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to LeMaitre Vascular. This insight gives a snapshot of analysts' ...Full story available on Benzinga.com

    Benzinga
  • Looking for Dividend Growth? Buy This Little-Known Healthcare Stock

    The healthcare company's dividend has soared in recent years.

    The Motley Fool
Page data last updated 07/22/2025 15:51:18 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included